Eu Yan Sang wants to keep going for another 100 years
To do that, the group plans to begin a three-year transformation
Singapore
RECENTLY delisted traditional Chinese medicine seller Eu Yan Sang plans to start a roughly three-year transformation that it hopes will set it up to last 100 years, group chief executive officer Richard Eu said, adding that he was open to the possibility that the homegrown heritage brand may be managed by someone outside the Eu family in as little as two years' time.
Even if it does relist eventually, that will likely happen only after at least five years, and the group may choose to float on the Hong Kong or Shanghai stock exchange instead of Singapore if majority of its business is in China by that time, he added.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
S&P slashes Boeing credit outlook as rating hovers above junk status
Honda to spend US$11 billion on EV strategy in Canada
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Mapletree Industrial Trust Q4 DPU rises 0.9% to S$0.0336
Nasdaq’s profit falls as shaky economy keeps IPO revival elusive
iFast Q1 net profit surges on ePension unit performance